All lobbying filings

VAN SCOYOC ASSOCIATES

VAN SCOYOC ASSOCIATES filed a Q3 report for SURESCRIPTS on October 19, 2026, reporting $40,000 in lobbying income.

Lobbying for SURESCRIPTS · Health information network

All filings by VAN SCOYOC ASSOCIATES · Everything SURESCRIPTS has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 19, 2026

Income

$40,000

What the client paid this registrant for the period.

Client based in

Virginia

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

S.2426, Equitable Community Access to Pharmacist Services Act, Entirety H.R.3164, Ensuring Community Access to Pharmacist Services Act, Entirety Data privacy Monitor the following: Interoperability SCRIPT electronic prescribing standard

Bills named in this filing 2

S. 2426
Equitable Community Access to Pharmacist Services Act
H.R. 3164
Ensuring Community Access to Pharmacist Services Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.